Your SlideShare is downloading. ×
  • Like
  • Save
randomized clinical trials I
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Now you can save presentations on your phone or tablet

Available for both IPhone and Android

Text the download link to your phone

Standard text messaging rates apply

randomized clinical trials I

  • 648 views
Published

Integrated Dentistry I …

Integrated Dentistry I
Third Year

Published in Health & Medicine , Business
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
No Downloads

Views

Total Views
648
On SlideShare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
2

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Randomized Controlled Trials Part 1
  • 2. Objectives • • • • Identify the RCT study design Discuss the various characteristics of RCTs Describe measures of effectiveness in RCTs Identify tools of critical appraisal of RCTs
  • 3. Study Types MAIN TYPES OF STUDY DESIGN Crosssectional Retrospective Cohort Observational Longitudinal Study Design Prospective Cohort Experimental Case-control
  • 4. Definition of RCTs • Is a prospective study design that randomly assigns participants into an experimental group and a control group.
  • 5. Definition of RCTs • Is a prospective study design that randomly assigns participants into an experimental group and a control group. • As the study is conducted, the only expected difference between the control and experimental groups is the outcome variable being studied.
  • 6. Definition of RCTs • Is a prospective study design that randomly assigns participants into an experimental group and a control group. • As the study is conducted, the only expected difference between the control and experimental groups is the outcome variable being studied. • It is the best design to assess causality.
  • 7. RCT Study Design Population sample Randomization & Allocation Concealment Intervention Disease Placebo NO Disease NO Disease Disease
  • 8. Characteristics of RCTs www.consort-statement.org/consort-statement
  • 9. Characteristics of RCTs • Prospective: – Allows the specific allocation and administration of intervention to a chosen population. – Increases the precision of the study compared to retrospective / observational data
  • 10. Characteristics of RCTs • Eligibility criteria for participants – A comprehensive description of the eligibility criteria used to select the trial participants is needed to help readers interpret the study. – a clear understanding of these criteria is one of several elements required to judge to whom the results of a trial apply (generalizability).
  • 11. Characteristics of RCTs • Settings and locations – crucial to judge the applicability and generalizability of a trial
  • 12. Characteristics of RCTs • Description of the interventions – Each intervention should be thoroughly described, including control interventions. – The intensity, duration, and frequency that best balances effectiveness and safety.
  • 13. Characteristics of RCTs • Defined pre-specified outcomes – What is the primary outcome? – How to measure it? – When to measure it? – Who will do the measurement?
  • 14. Characteristics of RCTs • How sample size was determined – The sample should be large enough to have a high probability (power) of detecting statistically significant and/or clinically important differences – The larger the sample the better we are at measuring the effect.
  • 15. Characteristics of RCTs • Randomization: – Every participant has an equal chance of being in either group – Ensures that all factors are equally distributed – Reduces selection and allocation biases – Eliminates the effect of confounders
  • 16. Characteristics of RCTs • Allocation Concealment. – The treatment allocation system should thus be set up so that the person enrolling participants does not know in advance which treatment the next person will get. – Happens before the intervention starts. – Could always take place.
  • 17. Characteristics of RCTs • Blinding (masking) – Withholding information about the assigned interventions from people involved in the trial who may potentially be influenced by this knowledge. – Participants and/or observers – Reduces observation bias. – Happens after the intervention starts. – Cannot always be implemented.
  • 18. Characteristics of RCTs • Statistical methods used to compare groups – It is essential to specify which statistical procedure was used for each analysis, and further clarification may be necessary in the results section of the report.
  • 19. Characteristics of RCTs • Statistical methods used to compare groups – It is essential to specify which statistical procedure was used for each analysis, and further clarification may be necessary in the results section of the report. – It is also important to describe details of the statistical analysis such as intention-to-treat analysis
  • 20. Critical Appraisal of the Evidence It is the process of systematically examining research to assess its validity and relevance before using it to make a clinical decision.
  • 21. Critical Appraisal of the Evidence • What is critical appraisal? It is the process of systematically examining research to assess its validity and relevance before using it to make a clinical decision. Importance to your patients (generalizability) The degree to which the results of the study are likely to be true, believable and free from bias
  • 22. Critical Appraisal Tools
  • 23. Revision 2003: information Mastery Working Group. Adapted from material developed at McMaster University
  • 24. Critically Appraise the Evidence Tools for Critical Appraisal Revision 2003: information Mastery Working Group. Adapted from material developed at McMaster University
  • 25. Critical Appraisal of the Evidence • Is the study valid? – Was the assignment of patients to treatment randomized? • Was the allocation to the different groups randomized? • How was randomization carried out? • Was it concealed?
  • 26. Critical Appraisal of the Evidence • Is the study valid? – Were all patients who entered the study properly accounted for at its conclusion? • Less than 30% of patients did not complete the study • Duration of study sufficient • Intention to treat analysis
  • 27. Critical Appraisal of the Evidence • Is the study valid? – Were patients, their physicians, and study personnel “blind” to treatment (masking)? • Single, double, triple blinding • How was it done? • Could there have been unblinding (unmasking)?
  • 28. Critical Appraisal of the Evidence • Is the study valid? – Were the groups similar at the start of the study? • Baseline prognostic factors (demographics, disease severity, etc) • If different, were they adjusted for?
  • 29. Critical Appraisal of the Evidence • Is the study valid? – Aside from the intervention, were the groups treated equally? • Co-intervention: – When participants take an intervention that has a similar effect as the intervention under study • contamination: – When participants in either of the groups receive the intervention intended for the other group • compliance
  • 30. Critical Appraisal of the Evidence • Is the study valid? – Overall, are the results of the study valid? • Yes… No
  • 31. Critical Appraisal of the Evidence • Is the study valid? • What are the results? • Can I apply the results locally?
  • 32. • To be continued…